Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0B3MV
|
||||
| Former ID |
DIB001260
|
||||
| Drug Name |
SSR-69071
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Chronic obstructive pulmonary disease [ICD9: 490-492, 494-496; ICD10:J40-J44, J47] | Terminated | [1] | ||
| Company |
Sanofi-Synthelabo
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C27H32N4O7S
|
||||
| Canonical SMILES |
S1(=O)(=O)N(C(=O)c2c1cc(cc2C(C)C)OC)COc1nc2n(c(=O)c1)cc<br />cc2OCCN1CCCCC1
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Elastase 1 | Target Info | Inhibitor | [2] | |
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800014569) | ||||
| REF 2 | Pivotal role for alpha1-antichymotrypsin in skin repair. J Biol Chem. 2011 Aug 19;286(33):28889-901. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.